B vitamins and n-3 fatty acids for brain development and function: Review of human studies

Annals of Nutrition and Metabolism

Volumn 60, Issue 4, 2012, Pages 272-292

  Van De Rest, Ondine ^a   Van Hooijdonk, Lenneke W A ^b   Doets, Esme ^a   Schiepers, Olga J G ^c   Eilander, Ans ^d   De Groot, Lisette C P G M ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b Netherlands Brain Foundation   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

Author keywords

B vitamins; Brain; Cognitive development; Cognitive function; n 3 fatty acids

Indexed keywords

ARACHIDONIC ACID; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; FOLIC ACID; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID; PYRIDOXINE;

ALZHEIMER DISEASE; BRAIN DEVELOPMENT; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; DEMENTIA; DEPRESSION; DEVELOPMENTAL STAGE; DRUG EFFECT; DRUG MEGADOSE; EPISODIC MEMORY; HUMAN; LACTATION; LANGUAGE DEVELOPMENT; LEARNING; LOW DRUG DOSE; MAJOR DEPRESSION; MEMORY; MILD COGNITIVE IMPAIRMENT; MOTOR PERFORMANCE; MULTIINFARCT DEMENTIA; NONHUMAN; NUTRITIONAL STATUS; PREGNANT WOMAN; PRENATAL PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME; VISUOMOTOR COORDINATION; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; WELLBEING;

BRAIN; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FOLIC ACID; HUMANS; NUTRITIONAL STATUS; VITAMIN B 12; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 84861822855     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000337945     Document Type: Review

References (177)

1. Stipanuk MH: Biochemical, Physiological and Molecular Aspects of Human Nutrition. St. Louis, Saunders Elsevier, 2006.
2. Guilarte TR: Vitamin B6 and cognitive development: recent research findings from human and animal studies. Nutr Rev 1993; 51: 193-198.
3. Hutto BR: Folate and cobalamin in psychiatric illness. Compr Psychiatry 1997; 38: 305-314.
4. Sugden C: One-carbon metabolism in psychiatric illness. Nutr Res Rev 2006; 19: 117-136.
5. Dror DK, Allen LH: Effect of vitamin B12 deficiency on neurodevelopment in infants: current knowledge and possible mechanisms. Nutr Rev 2008; 66: 250-255.
6. Reynolds E: Vitamin B12, folic acid, and the nervous system. Lancet Neurol 2006; 5: 949-960.
7. Fleming A: The role of folate in the prevention of neural tube defects: human and animal studies. Nutr Rev 2001; 59:S13-S20, discussion S21-S23.
8. Calvaresi E, Bryan J: B vitamins, cognition, and aging: a review. J Gerontol B Psychol Sci Soc Sci 2001; 56:P327-P339.
9. Smith AD, Refsum H: Vitamin B-12 and cognition in the elderly. Am J Clin Nutr 2009; 89: 707S-711S.
10. Refsum H: Folate, vitamin B12 and homocysteine in relation to birth defects and pregnancy outcome. Br J Nutr 2001; 85(suppl 2):S109-S113.
11. Molloy AM, Kirke PN, Brody LC, Scott JM, Mills JL: Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development. Food Nutr Bull 2008; 29:S101-S111, discussion S112-S115.
12. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270: 2693-2698.
13. Van Dam F, Van Gool WA: Hyperhomocysteinemia and Alzheimer's disease: a systematic review. Arch Gerontol Geriatr 2009; 48: 425-430.
14. Pawlosky RJ, Hibbeln JR, Novotny JA, Salem N Jr: Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res 2001; 42: 1257-1265.
15. Burdge GC, Jones AE, Wootton SA: Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 2002; 88: 355-363.
16. Burdge GC, Wootton SA: Conversion of alpha- linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002; 88: 411-420.
17. Gerster H: Can adults adequately convert alpha- linolenic acid (18: 3n-3) to eicosapentaenoic acid (20: 5n-3) and docosahexaenoic acid (22: 6n-3)? Int J Vitam Nutr Res 1998; 68: 159-173.
18. Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP: Compartmental modeling to quantify alpha-linolenic acid conversion after longer term intake of multiple tracer boluses. J Lipid Res 2005; 46: 1474-1483.
19. Brenna JT: Efficiency of conversion of alphalinolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 2002; 5: 127-132.
20. Vermunt SH, Mensink RP, Simonis MM, Hornstra G: Effects of dietary alpha-linolenic acid on the conversion and oxidation of 13C-alpha-linolenic acid. Lipids 2000; 35: 137-142.
21. Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP: Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 2006; 84: 44-53.
22. Emken EA, Adlof RO, Gulley RM: Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males. Biochim Biophys Acta 1994; 1213: 277-288.
23. Dobbing J, Sands J: Quantitative growth and development of human brain. Arch Dis Child 1973; 48: 757-767.
24. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW: Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum Dev 1980; 4: 131-138.
25. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW: Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 1980; 4: 121-129.
26. Martinez M: Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 1992; 120:S129-S138.
27. Cole GM, Ma QL, Frautschy SA: Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 213-221.
28. Schmitz G, Ecker J: The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008; 47: 147-155.
29. Young G, Conquer J: Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev 2005; 45: 1-28.
30. Smit EN, Muskiet FA, Boersma ER: The possible role of essential fatty acids in the pathophysiology of malnutrition: a review. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 241-250.
31. Food and Nutrition Board, Institute of Medicine, National Academy of Sciences: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. Washington, National Academy Press, 1998.
32. Health Council of the Netherlands: Towards an Adequate Intake of Vitamins and Minerals. The Hague, Health Council of the Netherlands, 2009.
33. Doets EL, Cavelaars AEJM, Dhonukshe- Rutten RAM, van 't Veer P, de Groot LCPGM: Explaining the variability in recommended intakes of folate, vitamin B12, iron and zinc for adults and elderly people. Public Health Nutr 2012; 15: 906-915.
34. Hermoso M, Tabacchi G, Iglesia-Altaba I, Bel-Serrat S, Moreno-Aznar LA, Garcia- Santos Y, Del Rosario Garcia-Luzardo M, Santana-Salguero B, Pena-Quintana L, Serra- Majem L, Hall Moran V, Dykes F, Decsi T, Benetou V, Plada M, Trichopoulou A, Raats MM, Doets EL, Berti C, Cetin I, Koletzko B: The nutritional requirements of infants. Towards EU alignment of reference values: the EURRECA network. Matern Child Nutr 2010; 6(suppl 2):55-83.
35. Iglesia I, Doets E, Bel-Serrat S, Roman B, Hermoso M, Pena Quintana L, Vucic V, Frost Andersen L, Lillegaard IT, Perez-Rodrigo C, Aranceta J, Cavelaars A, Decsi T, Serra-Majem LL, Gurinovic M, Cetin I, Koletzko B, Moreno LA: Physiological and public health basis for assessing micronutrient requirements in children and adolescents. The EURRECA network. Matern Child Nutr 2010; 6: 84-99.
36. Shane B, Contractor SF: Vitamin B 6 status and metabolism in pregnancy; in Tryfiates GP (ed): Vitamin B 6 Metabolism and Role in Growth. Westport, Food & Nutrition Press, 1980, pp 137-171.
37. Cleary RE, Lumeng L, Li T-K: Maternal and fetal plasma levels of pyridoxal phosphate at term: adequacy of vitamin B6 supplementation during pregnancy. Am J Obstet Gynecol 1975; 121: 25-28.
38. Lumeng L, Cleary RE, Wagner R, Yu P-L, Li T-K: Adequacy of vitamin B6 supplementation during pregnancy: a prospective study. Am J Clin Nutr 1976; 29: 1376-1383.
39. Kant AK, Block G: Dietary vitamin B-6 intake and food sources in the US population: NHANES II, 1976-1980. Am J Clin Nutr 1990; 52: 707-716.
40. Reynolds RD, Polansky M, Moser PB: Analyzed vitamin B-6 intakes of pregnant and postpartum lactating and nonlactating women. J Am Diet Assoc 1984; 84: 1339-1344.
41. Heller S, Salkeld RM, Korner WF: Vitamin B6 status in pregnancy. Am J Clin Nutr 1973; 26: 1339-1348.
42. McPartlin J, Halligan A, Scott JM, Darling M, Weir DG: Accelerated folate breakdown in pregnancy. Lancet 1993; 341: 148-149.
43. Rader JI: Folic acid fortification, folate status and plasma homocysteine. J Nutr 2002; 132: 2466S-2470S.
44. Casterline JE, Allen LH, Ruel MT: Vitamin B-12 deficiency is very prevalent in lactating Guatemalan women and their infants at three months postpartum. J Nutr 1997; 127: 1966-1972.
45. Fries ME, Chrisley BM, Driskell JA: Vitamin B6 status of a group of preschool children. Am J Clin Nutr 1981; 34: 2706-2710.
46. Gregory RL, Lowe S: National Diet and Nutrition Survey: Young People Aged 4-18 Years. London, The Stationery Office, 2000.
47. Benton D, Haller J, Fordy J: The vitamin status of young British adults. Int J Vitam Nutr Res 1997; 67: 34-40.
48. Al-Tahan J, Gonzalez-Gross M, Pietrzik K: B-vitamin status and intake in European adolescents. A review of the literature. Nutr Hosp 2006; 21: 452-465.
49. Allen LH: How common is vitamin B-12 deficiency? Am J Clin Nutr 2009; 89: 693S- 696S.
50. Kant AK, Moser-Veillon PB, Reynolds RD: Effect of age on changes in plasma, erythrocyte, and urinary B-6 vitamers after an oral vitamin B-6 load. Am J Clin Nutr 1988; 48: 1284-1290.
51. Lowik MR, van den Berg H, Westenbrink S, Wedel M, Schrijver J, Ockhuizen T: Doseresponse relationships regarding vitamin B-6 in elderly people: a nationwide nutritional survey (Dutch Nutritional Surveillance System). Am J Clin Nutr 1989; 50: 391-399.
52. Rose CS, Gyorgy P, Butler M, Andres R, Norris AH, Shock NW, Tobin J, Brin M, Spiegel H: Age differences in vitamin B6 status of 617 men. Am J Clin Nutr 1976; 29: 847-853.
53. Bates CJ, Pentieva KD, Prentice A, Mansoor MA, Finch S: Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. Br J Nutr 1999; 81: 191-201.
54. Senti FR, Pilch SM: Analysis of folate data from the second National Health and Nutrition Examination Survey (NHANES II). J Nutr 1985; 115: 1398-1402.
55. Bottiglieri T, Crellin R, Reynolds EH: Folate and neuropsychiatry; in Bailey LB (ed): Folate in Health and Disease. New York, Dekker, 1994, 435-463.
56. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ: Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr 2005; 82: 442-450.
57. McLean E, de Benoist B, Allen LH: Review of the magnitude of folate and vitamin B12 deficiencies worldwide. Food Nutr Bull 2008; 29:S38-S51.
58. McNulty H, Scott JM: Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status. Br J Nutr 2008; 99(suppl 3):S48-S54.
59. Dali-Youcef N, Andres E: An update on cobalamin deficiency in adults. QJM 2009; 102: 17-28.
60. Morris MS, Jacques PF, Rosenberg IH, Selhub J: Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007; 85: 193-200.
61. Selhub J, Morris MS, Jacques PF, Rosenberg IH: Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. Am J Clin Nutr 2009; 89: 702S-706S.
62. Veena SR, Krishnaveni GV, Srinivasan K, Wills AK, Muthayya S, Kurpad AV, Yajnik CS, Fall CH: Higher maternal plasma folate but not vitamin B-12 concentrations during pregnancy are associated with better cognitive function scores in 9- to 10-year-old children in South India. J Nutr 2010; 140: 1014-1022.
63. del Rio Garcia C, Torres-Sanchez L, Chen J, Schnaas L, Hernandez C, Osorio E, Portillo MG, Lopez-Carrillo L: Maternal MTHFR 677C 1 T genotype and dietary intake of folate and vitamin B(12): their impact on child neurodevelopment. Nutr Neurosci 2009; 12: 13-20.
64. Bhate V, Deshpande S, Bhat D, Joshi N, Ladkat R, Watve S, Fall C, de Jager CA, Refsum H, Yajnik C: Vitamin B12 status of pregnant Indian women and cognitive function in their 9-year-old children. Food Nutr Bull 2008; 29: 249-254.
65. Strand TA, Sunita T, Bhandari N, Schneede J, Refsum H, Ueland PM, Bahl R, Sommerfelt HM, Bhan MK: Vitamin B12, but not folate status predicts mental development scores in North Indian toddlers. Ann Nutr Metab 2009; 55: 691-692.
66. Eilander A, Muthayya S, van der Knaap H, Srinivasan K, Thomas T, Kok FJ, Kurpad AV, Osendarp SJ: Undernutrition, fatty acid and micronutrient status in relation to cognitive performance in Indian school children: a cross-sectional study. Br J Nutr 2010; 103: 1056-1064.
67. Dagnelie PC, van Staveren WA: Macrobiotic nutrition and child health: results of a population- based, mixed-longitudinal cohort study in The Netherlands. Am J Clin Nutr 1994; 59: 1187S-1196S.
68. Louwman MW, van Dusseldorp M, van de Vijver FJ, Thomas CM, Schneede J, Ueland PM, Refsum H, van Staveren WA: Signs of impaired cognitive function in adolescents with marginal cobalamin status. Am J Clin Nutr 2000; 72: 762-769.
69. Allen LH, Penland JG, Boy E, DeBaessa Y, Rogers LM: Cognitive and neuromotor performance of Guatemalan schoolers with deficient, marginal, and normal plasma vitamin B-12. FASEB J 1999; 13:A544.
70. Hardinsyah R, Hardinsyah ZL, Syarief H, Jalal F: Memory level of preschool children is effected by vitamin B12 supplementation. Ann Nutr Metab 2009; 55: 328.
71. Nourhashemi F, Gillette-Guyonnet S, Andrieu S, Ghisolfi A, Ousset PJ, Grandjean H, Grand A, Pous J, Vellas B, Albarede JL: Alzheimer disease: protective factors. Am J Clin Nutr 2000; 71: 643S-649S.
72. Smith AD: The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food Nutr Bull 2008; 29:S143-S172.
73. Sutton A, Abrams K, Jones D, Sheldon T, Song F: Methods for Meta-Analysis in Medical Research. Wiley Series in Probability and Mathematical Statistics. New York, Wiley, 2000, pp 57-86.
74. Khan KS, ter Riet G, Glanville J, Sowden AJ, Kleijnen J: Undertaking Systematic Reviews of Research on Effectiveness: CRD's Guidance for Those Carrying out of Commissioning Reviews. York, University of York, NHS Centre for Reviews and Dissemination, 2001.
75. Raman G, Tatsioni A, Chung M, Rosenberg IH, Lau J, Lichtenstein AH, Balk EM: Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function. J Nutr 2007; 137: 1789-1794.
76. Ellinson M, Thomas J, Patterson A: A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly. J Hum Nutr Diet 2004; 17: 371-383, quiz 385-387.
77. Vogel T, Dali-Youcef N, Kaltenbach G, Andres E: Homocysteine, vitamin B12, folate and cognitive functions: a systematic and critical review of the literature. Int J Clin Pract 2009; 63: 1061-1067.
78. Clarke R: B-vitamins and prevention of dementia. Proc Nutr Soc 2008; 67: 75-81.
79. Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A: Vitamin B12 and folate depletion in cognition: a review. Neurol India 2004; 52: 310-318.
80. Garcia A: Cobalamin and homocysteine in older adults: do we need to test for serum levels in the work-up of dementia? Alzheimers Dement 2007; 3: 318-324.
81. Wang HX: VITAMIN B12, folate, and Alzheimer's disease. Drug Dev Res 2002; 56: 111-122.
82. Dangour AD, Whitehouse PJ, Rafferty K, Mitchell SA, Smith L, Hawkesworth S, Vellas B: B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review. J Alzheimers Dis 2010; 22: 205-224.
83. Malouf R, Grimley Evans J: The effect of vitamin B6 on cognition. Cochrane Database Syst Rev 2003;(4):CD004393.
84. Balk EM, Raman G, Tatsioni A, Chung M, Lau J, Rosenberg IH: Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med 2007; 167: 21-30.
85. Stott DJ, MacIntosh G, Lowe GD, Rumley A, McMahon AD, Langhorne P, Tait RC, O'Reilly DS, Spilg EG, MacDonald JB, Mac- Farlane PW, Westendorp RG: Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr 2005; 82: 1320-1326.
86. Tolonen M, Schrijver J, Westermarck T, Halme M, Tuominen SE, Frilander A, Keinonen M, Sarna S: Vitamin B6 status of Finnish elderly. Comparison with Dutch younger adults and elderly. The effect of supplementation. Int J Vitam Nutr Res 1988; 58: 73-77.
87. Malouf R, Grimley Evans J: Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008;(4):CD004514.
88. Wald DS, Kasturiratne A, Simmonds M: Effect of folic acid, with or without other B vitamins, on cognitive decline: meta-analysis of randomized trials. Am J Med 2010; 123: 522-527.e2.
89. Malouf R, Areosa Sastre A: Vitamin B12 for cognition. Cochrane Database Syst Rev 2003;(3):CD004326.
90. Ford AH, Flicker L, McCaul K, van Bockxmeer F, Hegarty S, Hirani V, Fenner S, Almeida OP: The B-VITAGE trial: a randomized trial of homocysteine lowering treatment of depression in later life. Trials 2010; 11: 8.
91. de Benoist B: Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies. Food Nutr Bull 2008; 29:S238-S244.
92. Murakami K, Miyake Y, Sasaki S, Tanaka K, Arakawa M: Dietary folate, riboflavin, vitamin B-6, and vitamin B-12 and depressive symptoms in early adolescence: the Ryukyus Child Health Study. Psychosom Med 2010; 72: 763-768.
93. Merete C, Falcon LM, Tucker KL: Vitamin B6 is associated with depressive symptomatology in Massachusetts elders. J Am Coll Nutr 2008; 27: 421-427.
94. Hvas AM, Juul S, Bech P, Nexo E: Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom 2004; 73: 340-343.
95. Sanchez-Villegas A, Doreste J, Schlatter J, Pla J, Bes-Rastrollo M, Martinez-Gonzalez MA: Association between folate, vitamin B(6) and vitamin B(12) intake and depression in the SUN cohort study. J Hum Nutr Diet 2009; 22: 122-133.
96. Ng TP, Feng L, Niti M, Kua EH, Yap KB: Folate, vitamin B12, homocysteine, and depressive symptoms in a population sample of older Chinese adults. J Am Geriatr Soc 2009; 57: 871-876.
97. Beydoun MA, Shroff MR, Beydoun HA, Zonderman AB: Serum folate, vitamin B-12, and homocysteine and their association with depressive symptoms among U.S. adults. Psychosom Med 2010; 72: 862-873.
98. Robinson D, O'Luanaigh C, Tehee E, O'Connell H, Hamilton F, Chin A, Coen R, Molloy A, Scott J, Cunningham C, Lawlor B: Associations between holotranscobalamin, vitamin B12, homocysteine and depressive symptoms in community-dwelling elders. Int J Geriatr Psychiatry 2011; 26: 307-313.
99. Kamphuis MH, Geerlings MI, Grobbee DE, Kromhout D: Dietary intake of B(6-9-12) vitamins, serum homocysteine levels and their association with depressive symptoms: the Zutphen Elderly Study. Eur J Clin Nutr 2008; 62: 939-945.
100. Skarupski KA, Tangney C, Li H, Ouyang B, Evans DA, Morris MC: Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time. Am J Clin Nutr 2010; 92: 330-335.
101. Reynolds EH, Preece JM, Bailey J, Coppen A: Folate deficiency in depressive illness. Br J Psychiatry 1970; 117: 287-292.
102. Almeida OP, McCaul K, Hankey GJ, Norman P, Jamrozik K, Flicker L: Homocysteine and depression in later life. Arch Gen Psychiatry 2008; 65: 1286-1294.
103. Forti P, Rietti E, Pisacane N, Olivelli V, Dalmonte E, Mecocci P, Ravaglia G: Blood homocysteine and risk of depression in the elderly. Arch Gerontol Geriatr 2010; 51: 21-25.
104. Williams AL, Cotter A, Sabina A, Girard C, Goodman J, Katz DL: The role for vitamin B-6 as treatment for depression: a systematic review. Fam Pract 2005; 22: 532-537.
105. Ford AH, Flicker L, Thomas J, Norman P, Jamrozik K, Almeida OP: Vitamins B12, B6, and folic acid for onset of depressive symptoms in older men: results from a 2-year placebo-controlled randomized trial. J Clin Psychiatry 2008; 69: 1203-1209.
106. Almeida OP, Marsh K, Alfonso H, Flicker L, Davis TM, Hankey GJ: B-vitamins reduce the long-term risk of depression after stroke: the VITATOPS-DEP trial. Ann Neurol 2010; 68: 503-510.
107. Harris WS, Mozaffarian D, Lefevre M, Toner CD, Colombo J, Cunnane SC, Holden JM, Klurfeld DM, Morris MC, Whelan J: Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009; 139: 804S- 819S.
108. Innis SM: Omega-3 Fatty acids and neural development to 2 years of age: do we know enough for dietary recommendations? J Pediatr Gastroenterol Nutr 2009; 48(suppl 1):S16-S24.
109. Hibbeln JR, Davis JM: Considerations regarding neuropsychiatric nutritional requirements for intakes of omega-3 highly unsaturated fatty acids. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 179-186.
110. Mozaffarian D, Rimm EB: Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006; 296: 1885-1899.
111. Innis SM: Dietary omega 3 fatty acids and the developing brain. Brain Res 2008; 1237: 35-43.
112. Al MD, van Houwelingen AC, Kester AD, Hasaart TH, de Jong AE, Hornstra G: Maternal essential fatty acid patterns during normal pregnancy and their relationship to the neonatal essential fatty acid status. Br J Nutr 1995; 74: 55-68.
113. Otto SJ, van Houwelingen AC, Badart- Smook A, Hornstra G: Changes in the maternal essential fatty acid profile during early pregnancy and the relation of the profile to diet. Am J Clin Nutr 2001; 73: 302-307.
114. Elmadfa I, Kornsteiner M: Dietary fat intake - a global perspective. Ann Nutr Metab 2009; 54(suppl 1):8-14.
115. Innis SM: Fatty acids and early human development. Early Hum Dev 2007; 83: 761-766.
116. Uauy R, Castillo C: Lipid requirements of infants: implications for nutrient composition of fortified complementary foods. J Nutr 2003; 133: 2962S-2972S.
117. Uauy R, Dangour AD: Fat and fatty acid requirements and recommendations for infants of 0-2 years and children of 2-18 years. Ann Nutr Metab 2009; 55: 76-96.
118. Kris-Etherton PM, Taylor DS, Yu-Poth S, Huth P, Moriarty K, Fishell V, Hargrove RL, Zhao G, Etherton TD: Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000; 71: 179S-188S.
119. Sanders TA: Polyunsaturated fatty acids in the food chain in Europe. Am J Clin Nutr 2000; 71: 176S-178S.
120. Meyer BJ, Mann NJ, Lewis JL, Milligan GC, Sinclair AJ, Howe PR: Dietary intakes and food sources of omega-6 and omega-3 polyunsaturated fatty acids. Lipids 2003; 38: 391-398.
121. Ian Givens D, Gibbs RA: Current intakes of EPA and DHA in European populations and the potential of animal-derived foods to increase them. Proc Nutr Soc 2008; 67: 273-280.
122. The Netherlands Nutrition Centre: Zo eet Nederland, 1998: resultaten van de Voedselconsumptiepeiling 1998 (Results of the Dutch national food consumption survey 1998). The Hague, Voorlichtingsbureau voor de Voeding (The Netherlands Nutrition Centre), 1998.
123. Oomen CM, Feskens EJ, Rasanen L, Fidanza F, Nissinen AM, Menotti A, Kok FJ, Kromhout D: Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands. Am J Epidemiol 2000; 151: 999-1006.
124. Soderberg M, Edlund C, Kristensson K, Dallner G: Lipid compositions of different regions of the human brain during aging. J Neurochem 1990; 54: 415-423.
125. Giusto NM, Salvador GA, Castagnet PI, Pasquare SJ, Ilincheta de Boschero MG: Age-associated changes in central nervous system glycerolipid composition and metabolism. Neurochem Res 2002; 27: 1513-1523.
126. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH: Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000; 35: 1305-1312.
127. Tully AM, Roche HM, Doyle R, Fallon C, Bruce I, Lawlor B, Coakley D, Gibney MJ: Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr 2003; 89: 483-489.
128. Huang TL: Omega-3 fatty acids, cognitive decline, and Alzheimer's disease: a critical review and evaluation of the literature. J Alz heimers Dis 2010; 21: 673-690.
129. Cunnane SC, Plourde M, Pifferi F, Begin M, Feart C, Barberger-Gateau P: Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res 2009; 48: 239-256.
130. Hadders-Algra M: Prenatal long-chain polyunsaturated fatty acid status: the importance of a balanced intake of docosahexaenoic acid and arachidonic acid. J Perinat Med 2008; 36: 101-109.
131. Ryan AS, Astwood JD, Gautier S, Kuratko CN, Nelson EB, Salem N Jr: Effects of longchain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: A review of human studies. Prostaglandins Leukot Essent Fatty Acids 2010; 82: 305-314.
132. Eilander A, Hundscheid DC, Osendarp SJ, Transler C, Zock PL: Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. Prostaglandins Leukot Essent Fatty Acids 2007; 76: 189-203.
133. Hoffman DR, Boettcher JA, Diersen- Schade DA: Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids 2009; 81: 151-158.
134. Simmer K: Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2001;(4):CD000376.
135. Simmer K, Patole SK, Rao SC: Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2008;(1):CD000376.
136. Ryan AS, Nelson EB: Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomized, placebo-controlled, double-blind study. Clin Pediatr (Phila) 2008; 47: 355-362.
137. Dalton A, Wolmarans P, Witthuhn RC, van Stuijvenberg ME, Swanevelder SA, Smuts CM: A randomised control trial in schoolchildren showed improvement in cognitive function after consuming a bread spread, containing fish flour from a marine source. Prostaglandins Leukot Essent Fatty Acids 2009; 80: 143-149.
138. Kennedy DO, Jackson PA, Elliott JM, Scholey AB, Robertson BC, Greer J, Tiplady B, Buchanan T, Haskell CF: Cognitive and mood effects of 8 weeks' supplementation with 400 mg or 1,000 mg of the omega-3 essential fatty acid docosahexaenoic acid (DHA) in healthy children aged 10-12 years. Nutr Neurosci 2009; 12: 48-56.
139. Kirby A, Woodward A, Jackson S, Wang Y, Crawford MA: A double-blind, placebocontrolled study investigating the effects of omega-3 supplementation in children aged 8-10 years from a mainstream school population. Res Dev Disabil 2010; 31: 718-730.
140. McNamara RK, Able J, Jandacek R, Rider T, Tso P, Eliassen JC, Alfieri D, Weber W, Jarvis K, DelBello MP, Strakowski SM, Adler CM: Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Am J Clin Nutr 2010; 91: 1060-1067.
141. Muthayya S, Eilander A, Transler C, Thomas T, van der Knaap HC, Srinivasan K, van Klinken BJ, Osendarp SJ, Kurpad AV: Effect of fortification with multiple micronutrients and n-3 fatty acids on growth and cognitive performance in Indian schoolchildren: the CHAMPION (Children's Health and Mental Performance Influenced by Optimal Nutrition) Study. Am J Clin Nutr 2009; 89: 1766-1775.
142. Osendarp SJ, Baghurst KI, Bryan J, Calvaresi E, Hughes D, Hussaini M, Karyadi SJ, van Klinken BJ, van der Knaap HC, Lukito W, Mikarsa W, Transler C, Wilson C: Effect of a 12-mo micronutrient intervention on learning and memory in well-nourished and marginally nourished school-aged children: 2 parallel, randomized, placebocontrolled studies in Australia and Indonesia. Am J Clin Nutr 2007; 86: 1082-1093.
143. de Groot RH, Hornstra G, Jolles J: Exploratory study into the relation between plasma phospholipid fatty acid status and cognitive performance. Prostaglandins Leukot Essent Fatty Acids 2007; 76: 165-172.
144. Cederholm T, Palmblad J: Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Curr Opin Clin Nutr Metab Care 2010; 13: 150-155.
145. Kesse-Guyot E, Peneau S, Ferry M, Jeandel C, Hercberg S, Galan P; SU.VI.MAX 2 Research Group: Thirteen-year prospective study between fish consumption, longchain n-3 fatty acid intakes and cognitive function. J Nutr Health Aging 2011; 15: 115-120.
146. Lim W, Gammack J, Van Niekerk J, Dangour A: Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst Rev 2006;(1):CD005379.
147. Terano T, Fujishiro S, Ban T, Yamamoto K, Tanaka T, Noguchi Y, Tamura Y, Yazawa K, Hirayama T: Docosahexaenoic acid supplementation improves the moderately severe dementia from thrombotic cerebrovascular diseases. Lipids 1999; 34(suppl): S345-S346.
148. Yehuda S, Rabinovtz S, Carasso RL, Mostofsky DI: Essential fatty acids preparation (SR-3) improves Alzheimer's patients quality of life. Int J Neurosci 1996; 87: 141-149.
149. van de Rest O, Geleijnse JM, Kok FJ, van Staveren WA, Dullemeijer C, Olderikkert MG, Beekman AT, de Groot CP: Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial. Neurology 2008; 71: 430-438.
150. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J: Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 2006; 63: 1402-1408.
151. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang SY: The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 1538-1544.
152. Johnson EJ, McDonald K, Caldarella SM, Chung HY, Troen AM, Snodderly DM: Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women. Nutr Neurosci 2008; 11: 75-83.
153. Fotuhi M, Mohassel P, Yaffe K: Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol 2009; 5: 140-152.
154. Quinn JF: A clinical trial of docosahexaenoic acid (DHA) for the treatment of Alzheimer's Disease. Alzheimers Dement 2009; 5:P84.
155. Yurko-Mauro K: Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline. Curr Alzheimer Res 2010; 7: 190-196.
156. Dangour AD, Allen E, Elbourne D, Fasey N, Fletcher AE, Hardy P, Holder GE, Knight R, Letley L, Richards M, Uauy R: Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr 2010; 91: 1725-1732.
157. Gillette-Guyonnet S, Andrieu S, Dantoine T, Dartigues JF, Touchon J, Vellas B: Commentary on 'A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.' The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Alzheimers Dement 2009; 5: 114-121.
158. Ramakrishnan U, Imhoff-Kunsch B, DiGirolamo AM: Role of docosahexaenoic acid in maternal and child mental health. Am J Clin Nutr 2009; 89: 958S-962S
159. Mamalakis G, Kiriakakis M, Tsibinos G, Kafatos A: Depression and adipose polyunsaturated fatty acids in an adolescent group. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 289-294.
160. Mamalakis G, Kiriakakis M, Tsibinos G, Hatzis C, Flouri S, Mantzoros C, Kafatos A: Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents. Pharmacol Biochem Behav 2006; 85: 474-479.
161. Nemets H, Nemets B, Apter A, Bracha Z, Belmaker RH: Omega-3 treatment of childhood depression: a controlled, doubleblind pilot study. Am J Psychiatry 2006; 163: 1098-1100.
162. Osher Y, Belmaker RH: Omega-3 fatty acids in depression: a review of three studies. CNS Neurosci Ther 2009; 15: 128-133.
163. Hibbeln JR: Fish consumption and major depression. Lancet 1998; 351: 1213.
164. Appleton KM, Rogers PJ, Ness AR: Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials. Nutr Res Rev 2008; 21: 13-41.
165. Bountziouka V, Polychronopoulos E, Zeimbekis A, Papavenetiou E, Ladoukaki E, Papairakleous N, Gotsis E, Metallinos G, Lionis C, Panagiotakos D: Long-term fish intake is associated with less severe depressive symptoms among elderly men and women: the MEDIS (MEDiterranean ISlands Elderly) epidemiological study. J Aging Health 2009; 21: 864-880.
166. Murakami K, Mizoue T, Sasaki S, Ohta M, Sato M, Matsushita Y, Mishima N: Dietary intake of folate, other B vitamins, and omega- 3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults. Nutrition 2008; 24: 140-147.
167. Colangelo LA, He K, Whooley MA, Daviglus ML, Liu K: Higher dietary intake of long-chain omega-3 polyunsaturated fatty acids is inversely associated with depressive symptoms in women. Nutrition 2009; 25: 1011-1019.
168. Sanchez-Villegas A, Henriquez P, Figueiras A, Ortuno F, Lahortiga F, Martinez-Gonzalez MA: Long chain omega-3 fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr 2007; 46: 337-346.
169. Lin PY, Huang SY, Su KP: A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010; 68: 140-147.
170. Conklin SM, Manuck SB, Yao JK, Flory JD, Hibbeln JR, Muldoon MF: High omega-6 and low omega-3 fatty acids are associated with depressive symptoms and neuroticism. Psychosom Med 2007; 69: 932-934.
171. Schiepers OJ, de Groot RH, Jolles J, van Boxtel MP: Plasma phospholipid fatty acid status and depressive symptoms: association only present in the clinical range. J Affect Disord 2009; 118: 209-214.
172. Appleton KM, Gunnell D, Peters TJ, Ness AR, Kessler D, Rogers PJ: No clear evidence of an association between plasma concentrations of n-3 long-chain polyunsaturated fatty acids and depressed mood in a nonclinical population. Prostaglandins Leukot Essent Fatty Acids 2008; 78: 337-342.
173. Appleton KM, Rogers PJ, Ness AR: Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010; 91: 757-770.
174. Martins JG: EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 2009; 28: 525-542.
175. Rondanelli M, Giacosa A, Opizzi A, Pelucchi C, La Vecchia C, Montorfano G, Negroni M, Berra B, Politi P, Rizzo AM: Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr 2010; 29: 55-64.
176. Hadders-Algra M, Bouwstra H, van Goor SA, Dijck-Brouwer DA, Muskiet FA: Prenatal and early postnatal fatty acid status and neurodevelopmental outcome. J Perinat Med 2007; 35(suppl 1):S28-S34.
177. Benton D: The influence of children's diet on their cognition and behavior. Eur J Nutr 2008; 47(suppl 3):25-37.